SWIFTT is a forest management platform that combines the rich Copernicus Sentinel satellite data and powerful machine learning models. It helps foresters identify changes in tree health, map dieback in their forests and coordinate sanitary cuts, map windthrow damage, and identify areas at high risk of and damaged by wildfires.

An international group have discovered associations between pathogenic variants of the BRCA 1 and 2 genes and four types of cancer. Published in ESMO Open, the findings expand the potential for personalized medicine to several cancer types that currently have limited treatment options and poor prognoses.

Researchers at China Agricultural University have developed an ovarian follicle-based angiogenesis microphysiological system, or OF-AMPS, for rapid and quantitative screening of anti-angiogenic compounds. The platform uses growing ovarian follicles as natural angiogenic microphysiological units and forms complex 3D vascular networks within 24 hours without exogenous VEGF. In a screen of 406 small molecules, OF-AMPS identified compounds with selective anti-angiogenic activity, predicted in vivo efficacy, and helped prioritize Ki8751, which later suppressed tumor growth in a human xenograft model.

An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world, led by Radboudumc, are calling for action against drug‑resistant fungi. Their call has been published in Nature Medicine.

Seismicity decreases with depth, though it turns to increase in the mantle transition zone. It has been believed that pressure-induced phase transitions of olivine are the cause of high seismicity in the mantle transition zone. We experimentally showed that a diffusionless phase transition of olivine to poirierite triggers faulting. Our findings provide a natural explanation for the cause of high seismicity in the strongly deformed areas of ‘cold’ deep subducted slabs.

AilsynBio, a drug discovery startup incubated from The University of Hong Kong (HKU), announced an innovative project cooperation agreement with Dong-E-E-Jiao Co., Ltd., a subsidiary of China Resources Pharmaceutical Group. This partnership aims to integrate artificial intelligence (AI) with traditional medicine technologies to empower biopharmaceutical innovation.